 Brian Reemtsen
Concepts (214)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cardiac Surgical Procedures | 10 | 2017 | 331 | 2.070 |
Why?
| | Extracellular Matrix | 3 | 2017 | 116 | 1.440 |
Why?
| | Heart Defects, Congenital | 12 | 2020 | 625 | 1.340 |
Why?
| | Heart Ventricles | 7 | 2020 | 260 | 1.180 |
Why?
| | Postoperative Complications | 6 | 2019 | 1099 | 0.690 |
Why?
| | Heart Valve Prosthesis Implantation | 5 | 2025 | 103 | 0.680 |
Why?
| | Ebstein Anomaly | 3 | 2008 | 8 | 0.590 |
Why?
| | Vascular Grafting | 1 | 2018 | 6 | 0.550 |
Why?
| | Blalock-Taussig Procedure | 1 | 2018 | 18 | 0.550 |
Why?
| | Anticoagulants | 2 | 2018 | 280 | 0.540 |
Why?
| | Blood Vessel Prosthesis | 2 | 2018 | 89 | 0.540 |
Why?
| | Infant | 16 | 2024 | 3805 | 0.530 |
Why?
| | Heparin | 1 | 2018 | 86 | 0.520 |
Why?
| | Mitral Valve Insufficiency | 1 | 2017 | 56 | 0.500 |
Why?
| | Funnel Chest | 2 | 2008 | 11 | 0.470 |
Why?
| | Foreign-Body Reaction | 1 | 2015 | 9 | 0.470 |
Why?
| | Heart Septum | 1 | 2015 | 21 | 0.460 |
Why?
| | Cardiac Catheterization | 5 | 2024 | 229 | 0.460 |
Why?
| | Heart Valves | 1 | 2015 | 31 | 0.450 |
Why?
| | Calcinosis | 1 | 2015 | 53 | 0.450 |
Why?
| | Intestinal Mucosa | 1 | 2015 | 229 | 0.420 |
Why?
| | Tetralogy of Fallot | 3 | 2020 | 83 | 0.420 |
Why?
| | Prosthesis Implantation | 2 | 2014 | 49 | 0.380 |
Why?
| | Heart Valve Prosthesis | 3 | 2025 | 89 | 0.370 |
Why?
| | Child, Preschool | 14 | 2024 | 4162 | 0.340 |
Why?
| | Treatment Outcome | 14 | 2018 | 5595 | 0.340 |
Why?
| | Retrospective Studies | 14 | 2024 | 6819 | 0.340 |
Why?
| | Inflammation | 1 | 2015 | 652 | 0.340 |
Why?
| | Female | 25 | 2024 | 28782 | 0.320 |
Why?
| | Male | 27 | 2024 | 27435 | 0.320 |
Why?
| | Cardiopulmonary Bypass | 4 | 2015 | 91 | 0.300 |
Why?
| | Heart Transplantation | 4 | 2025 | 327 | 0.300 |
Why?
| | Survival Rate | 5 | 2019 | 949 | 0.300 |
Why?
| | Cor Triatriatum | 1 | 2008 | 3 | 0.290 |
Why?
| | Vena Cava, Inferior | 2 | 2008 | 62 | 0.290 |
Why?
| | Humans | 35 | 2025 | 53230 | 0.280 |
Why?
| | Heart Septal Defects, Atrial | 1 | 2008 | 45 | 0.280 |
Why?
| | Pulmonary Valve | 3 | 2018 | 61 | 0.270 |
Why?
| | Transcriptome | 3 | 2020 | 367 | 0.260 |
Why?
| | Infant, Newborn | 7 | 2019 | 2913 | 0.250 |
Why?
| | Child | 14 | 2025 | 7379 | 0.250 |
Why?
| | Follow-Up Studies | 5 | 2017 | 2318 | 0.250 |
Why?
| | Palliative Care | 2 | 2010 | 195 | 0.240 |
Why?
| | Adolescent | 12 | 2024 | 6907 | 0.240 |
Why?
| | Los Angeles | 5 | 2017 | 31 | 0.240 |
Why?
| | Hypoplastic Left Heart Syndrome | 1 | 2007 | 97 | 0.230 |
Why?
| | Heart | 2 | 2017 | 350 | 0.220 |
Why?
| | Heart Valve Diseases | 1 | 2025 | 55 | 0.210 |
Why?
| | Echocardiography | 2 | 2017 | 409 | 0.210 |
Why?
| | Tricuspid Valve Insufficiency | 2 | 2018 | 18 | 0.210 |
Why?
| | Peptide Fragments | 2 | 2015 | 209 | 0.210 |
Why?
| | Anesthesia, General | 1 | 2024 | 99 | 0.210 |
Why?
| | Heart-Assist Devices | 2 | 2017 | 157 | 0.200 |
Why?
| | Coronary Vessel Anomalies | 1 | 2024 | 37 | 0.200 |
Why?
| | Thrombosis | 2 | 2017 | 250 | 0.190 |
Why?
| | Sternum | 1 | 2002 | 12 | 0.190 |
Why?
| | Magnetic Resonance Imaging | 3 | 2017 | 1583 | 0.170 |
Why?
| | Reoperation | 2 | 2017 | 476 | 0.170 |
Why?
| | Wnt Proteins | 2 | 2019 | 104 | 0.170 |
Why?
| | DiGeorge Syndrome | 1 | 2020 | 18 | 0.160 |
Why?
| | Time Factors | 5 | 2017 | 2991 | 0.160 |
Why?
| | Polytetrafluoroethylene | 2 | 2018 | 33 | 0.150 |
Why?
| | Perfusion | 1 | 2019 | 49 | 0.150 |
Why?
| | Cardiac Valve Annuloplasty | 1 | 2018 | 2 | 0.150 |
Why?
| | Tricuspid Valve | 1 | 2018 | 23 | 0.140 |
Why?
| | Contrast Media | 2 | 2017 | 178 | 0.140 |
Why?
| | Gene Expression Profiling | 3 | 2020 | 1112 | 0.140 |
Why?
| | Graft Survival | 2 | 2017 | 157 | 0.140 |
Why?
| | Norwood Procedures | 1 | 2019 | 61 | 0.140 |
Why?
| | Cerebrovascular Circulation | 1 | 2019 | 132 | 0.140 |
Why?
| | Pulmonary Valve Insufficiency | 1 | 2018 | 27 | 0.140 |
Why?
| | Tachycardia, Ventricular | 1 | 2018 | 44 | 0.130 |
Why?
| | Transplants | 1 | 2018 | 19 | 0.130 |
Why?
| | Hemorrhage | 2 | 2017 | 226 | 0.130 |
Why?
| | Critical Illness | 1 | 2020 | 316 | 0.130 |
Why?
| | Cell Proliferation | 2 | 2020 | 1031 | 0.130 |
Why?
| | Heart Septal Defects | 1 | 2017 | 14 | 0.130 |
Why?
| | Endocarditis | 1 | 2017 | 31 | 0.130 |
Why?
| | California | 1 | 2017 | 93 | 0.130 |
Why?
| | Physicians | 1 | 2020 | 242 | 0.130 |
Why?
| | Off-Label Use | 1 | 2016 | 24 | 0.120 |
Why?
| | Image Interpretation, Computer-Assisted | 1 | 2017 | 98 | 0.120 |
Why?
| | Bioprosthesis | 3 | 2025 | 41 | 0.120 |
Why?
| | Fibroblast Growth Factors | 1 | 2015 | 52 | 0.110 |
Why?
| | Necrosis | 1 | 2015 | 169 | 0.110 |
Why?
| | Prosthesis Design | 3 | 2025 | 266 | 0.110 |
Why?
| | Fibrosis | 1 | 2015 | 198 | 0.110 |
Why?
| | Heart, Artificial | 1 | 2014 | 3 | 0.110 |
Why?
| | Premedication | 1 | 2014 | 17 | 0.110 |
Why?
| | Hirudins | 1 | 2014 | 23 | 0.110 |
Why?
| | Myocardium | 1 | 2016 | 471 | 0.100 |
Why?
| | Animals, Newborn | 3 | 2020 | 357 | 0.100 |
Why?
| | Databases, Factual | 1 | 2015 | 742 | 0.090 |
Why?
| | Echocardiography, Transesophageal | 2 | 2008 | 63 | 0.090 |
Why?
| | Severity of Illness Index | 2 | 2018 | 1049 | 0.090 |
Why?
| | Heart Failure | 1 | 2017 | 531 | 0.080 |
Why?
| | Acute Kidney Injury | 1 | 2015 | 399 | 0.080 |
Why?
| | Risk Factors | 5 | 2019 | 4017 | 0.080 |
Why?
| | Pulmonary Circulation | 2 | 2007 | 27 | 0.080 |
Why?
| | Anastomosis, Surgical | 2 | 2007 | 69 | 0.080 |
Why?
| | Tachycardia, Supraventricular | 1 | 2010 | 36 | 0.080 |
Why?
| | Risk Assessment | 3 | 2010 | 1368 | 0.080 |
Why?
| | Fontan Procedure | 1 | 2010 | 67 | 0.080 |
Why?
| | Epithelial-Mesenchymal Transition | 2 | 2020 | 56 | 0.080 |
Why?
| | Coronary Angiography | 2 | 2024 | 369 | 0.070 |
Why?
| | Adult | 8 | 2018 | 14534 | 0.070 |
Why?
| | Failure to Thrive | 1 | 2008 | 19 | 0.070 |
Why?
| | Catheter Ablation | 1 | 2010 | 125 | 0.070 |
Why?
| | Mice, Inbred C57BL | 3 | 2020 | 1925 | 0.070 |
Why?
| | Venous Pressure | 1 | 2008 | 17 | 0.070 |
Why?
| | Thoracoscopy | 1 | 2008 | 17 | 0.070 |
Why?
| | Coronary Thrombosis | 1 | 2008 | 22 | 0.070 |
Why?
| | Coronary Aneurysm | 1 | 2008 | 18 | 0.070 |
Why?
| | Constriction, Pathologic | 1 | 2008 | 91 | 0.070 |
Why?
| | Pneumothorax | 1 | 2008 | 20 | 0.070 |
Why?
| | Mucocutaneous Lymph Node Syndrome | 1 | 2008 | 21 | 0.070 |
Why?
| | Phlebography | 1 | 2008 | 55 | 0.070 |
Why?
| | Respiratory Paralysis | 1 | 2007 | 6 | 0.070 |
Why?
| | Signal Transduction | 3 | 2020 | 1748 | 0.070 |
Why?
| | Pericardium | 1 | 2008 | 32 | 0.070 |
Why?
| | Lung Transplantation | 1 | 2008 | 39 | 0.070 |
Why?
| | Biopsy, Needle | 1 | 2008 | 181 | 0.070 |
Why?
| | Bronchoscopy | 1 | 2008 | 78 | 0.070 |
Why?
| | Cohort Studies | 3 | 2019 | 1557 | 0.070 |
Why?
| | Diaphragm | 1 | 2007 | 32 | 0.070 |
Why?
| | Prosthesis Failure | 1 | 2008 | 113 | 0.070 |
Why?
| | Hypotension | 1 | 2008 | 62 | 0.070 |
Why?
| | Device Removal | 1 | 2008 | 89 | 0.070 |
Why?
| | Gene Regulatory Networks | 2 | 2019 | 112 | 0.070 |
Why?
| | Abnormalities, Multiple | 1 | 2008 | 166 | 0.070 |
Why?
| | Graft Rejection | 1 | 2008 | 166 | 0.070 |
Why?
| | Blood Circulation | 1 | 2007 | 9 | 0.070 |
Why?
| | Organ Size | 1 | 2007 | 226 | 0.070 |
Why?
| | Scimitar Syndrome | 1 | 2007 | 6 | 0.060 |
Why?
| | Heart Atria | 1 | 2007 | 64 | 0.060 |
Why?
| | Ventricular Dysfunction, Right | 1 | 2007 | 32 | 0.060 |
Why?
| | Pulmonary Veins | 1 | 2007 | 42 | 0.060 |
Why?
| | Infant, Low Birth Weight | 1 | 2007 | 77 | 0.060 |
Why?
| | Vascular Surgical Procedures | 1 | 2008 | 171 | 0.060 |
Why?
| | Young Adult | 4 | 2018 | 4511 | 0.060 |
Why?
| | Ultrasonography | 1 | 2007 | 426 | 0.060 |
Why?
| | Pulmonary Artery | 1 | 2007 | 142 | 0.060 |
Why?
| | Incidence | 2 | 2019 | 1085 | 0.060 |
Why?
| | Proportional Hazards Models | 2 | 2018 | 445 | 0.050 |
Why?
| | Infant, Premature | 1 | 2007 | 331 | 0.050 |
Why?
| | Predictive Value of Tests | 2 | 2017 | 934 | 0.050 |
Why?
| | Recovery of Function | 2 | 2018 | 203 | 0.050 |
Why?
| | Aorta, Thoracic | 1 | 2024 | 101 | 0.050 |
Why?
| | Hospital Mortality | 2 | 2019 | 457 | 0.050 |
Why?
| | Traction | 1 | 2002 | 7 | 0.050 |
Why?
| | Prognosis | 2 | 2018 | 2118 | 0.050 |
Why?
| | Prospective Studies | 2 | 2019 | 2411 | 0.050 |
Why?
| | Middle Aged | 4 | 2018 | 13419 | 0.050 |
Why?
| | Orthopedic Procedures | 1 | 2002 | 71 | 0.050 |
Why?
| | Gastrostomy | 1 | 2020 | 56 | 0.040 |
Why?
| | E2F1 Transcription Factor | 1 | 2019 | 6 | 0.040 |
Why?
| | Cyclic AMP Response Element-Binding Protein | 1 | 2019 | 34 | 0.040 |
Why?
| | Genome | 1 | 2019 | 58 | 0.040 |
Why?
| | Tracheostomy | 1 | 2020 | 76 | 0.040 |
Why?
| | Circulatory Arrest, Deep Hypothermia Induced | 1 | 2019 | 3 | 0.040 |
Why?
| | Animals | 3 | 2020 | 13526 | 0.040 |
Why?
| | Mice | 2 | 2020 | 5982 | 0.040 |
Why?
| | Poisson Distribution | 1 | 2018 | 36 | 0.040 |
Why?
| | Critical Care | 1 | 2020 | 215 | 0.030 |
Why?
| | Retinoblastoma Protein | 1 | 2017 | 19 | 0.030 |
Why?
| | Genes, cdc | 1 | 2017 | 6 | 0.030 |
Why?
| | Echocardiography, Doppler | 1 | 2018 | 56 | 0.030 |
Why?
| | Hemodynamics | 1 | 2018 | 236 | 0.030 |
Why?
| | Delivery of Health Care | 1 | 2020 | 317 | 0.030 |
Why?
| | Propensity Score | 1 | 2018 | 170 | 0.030 |
Why?
| | Autopsy | 1 | 2017 | 46 | 0.030 |
Why?
| | Echocardiography, Doppler, Color | 1 | 2016 | 21 | 0.030 |
Why?
| | Observer Variation | 1 | 2017 | 138 | 0.030 |
Why?
| | Myoblasts, Cardiac | 1 | 2016 | 3 | 0.030 |
Why?
| | Dopamine and cAMP-Regulated Phosphoprotein 32 | 1 | 2016 | 2 | 0.030 |
Why?
| | Multivariate Analysis | 1 | 2018 | 598 | 0.030 |
Why?
| | Down-Regulation | 1 | 2017 | 344 | 0.030 |
Why?
| | Age Distribution | 1 | 2016 | 175 | 0.030 |
Why?
| | Phosphorylation | 1 | 2017 | 533 | 0.030 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2016 | 147 | 0.030 |
Why?
| | Patient Safety | 1 | 2016 | 103 | 0.030 |
Why?
| | Gene Expression | 1 | 2017 | 618 | 0.030 |
Why?
| | Gene Expression Regulation | 1 | 2019 | 1003 | 0.030 |
Why?
| | Cross-Sectional Studies | 1 | 2020 | 1723 | 0.030 |
Why?
| | Antithrombins | 1 | 2014 | 22 | 0.030 |
Why?
| | Reproducibility of Results | 1 | 2017 | 1219 | 0.030 |
Why?
| | Compassionate Use Trials | 1 | 2013 | 5 | 0.020 |
Why?
| | Hyperbilirubinemia | 1 | 2013 | 8 | 0.020 |
Why?
| | Chronic Disease | 1 | 2015 | 580 | 0.020 |
Why?
| | Body Size | 1 | 2013 | 32 | 0.020 |
Why?
| | Multiple Organ Failure | 1 | 2013 | 51 | 0.020 |
Why?
| | RNA, Messenger | 1 | 2016 | 1133 | 0.020 |
Why?
| | Waiting Lists | 1 | 2013 | 56 | 0.020 |
Why?
| | Recombinant Proteins | 1 | 2014 | 489 | 0.020 |
Why?
| | Cells, Cultured | 1 | 2016 | 1569 | 0.020 |
Why?
| | Mortality | 1 | 2013 | 98 | 0.020 |
Why?
| | Liver Diseases | 1 | 2013 | 81 | 0.020 |
Why?
| | Risk | 1 | 2013 | 306 | 0.020 |
Why?
| | Cause of Death | 1 | 2013 | 156 | 0.020 |
Why?
| | Equipment Design | 1 | 2013 | 290 | 0.020 |
Why?
| | Comorbidity | 1 | 2013 | 638 | 0.020 |
Why?
| | Kidney Diseases | 1 | 2013 | 230 | 0.020 |
Why?
| | Heart Diseases | 1 | 2013 | 221 | 0.020 |
Why?
| | Extracorporeal Membrane Oxygenation | 1 | 2013 | 305 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2016 | 3494 | 0.020 |
Why?
| | Recurrence | 1 | 2010 | 694 | 0.020 |
Why?
| | United States | 1 | 2019 | 5409 | 0.020 |
Why?
| | Phrenic Nerve | 1 | 2007 | 6 | 0.020 |
Why?
| | Transplantation, Homologous | 1 | 2008 | 154 | 0.020 |
Why?
| | Stroke | 1 | 2013 | 520 | 0.020 |
Why?
| | Monitoring, Physiologic | 1 | 2008 | 122 | 0.020 |
Why?
| | Sensitivity and Specificity | 1 | 2008 | 867 | 0.010 |
Why?
| | Immunohistochemistry | 1 | 2008 | 975 | 0.010 |
Why?
| | Aged | 1 | 2016 | 10429 | 0.010 |
Why?
|
|
Reemtsen's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|